Wall Street analysts expect International Flavors (IFF) to post quarterly earnings of $1.12 per share in its upcoming report, which indicates a year-over-year decline of 0.9%. Revenues are expected to be $2.83 billion, down 2.2% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 1.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some International Flavors metrics that Wall Street analysts commonly model and monitor.
It is projected by analysts that the 'Net Sales- Nourish' will reach $1.45 billion. The estimate indicates a change of -2.8% from the prior-year quarter.
The consensus estimate for 'Net sales- Scent' stands at $609.74 million. The estimate indicates a change of -5.5% from the prior-year quarter.
Analysts' assessment points toward 'Net Sales- Pharma Solutions' reaching $233.97 million. The estimate indicates a year-over-year change of +3.1%.
Analysts expect 'Net Sales- Health & Biosciences' to come in at $532.05 million. The estimate indicates a change of +0.2% from the prior-year quarter.
Analysts forecast 'Adjusted Operating EBITDA- Nourish' to reach $216.88 million. Compared to the current estimate, the company reported $216 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Pharma Solutions' should arrive at $45.50 million. The estimate compares to the year-ago value of $46 million.
According to the collective judgment of analysts, 'Adjusted Operating EBITDA- Scent' should come in at $140.59 million. The estimate compares to the year-ago value of $157 million.
The consensus among analysts is that 'Adjusted Operating EBITDA- Health & Biosciences' will reach $159.94 million. Compared to the current estimate, the company reported $159 million in the same quarter of the previous year.
View all Key Company Metrics for International Flavors here>>>
Over the past month, International Flavors shares have recorded returns of -0.2% versus the Zacks S&P 500 composite's -0.7% change. Based on its Zacks Rank #3 (Hold), IFF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Flavors & Fragrances Inc. (IFF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
